Menthol 1% and thymol 1% rubefacient in rosemary spirit
CGR-ES-079 · FN/2003/PO/026 SOLUCIÓN RUBEFACIENTE
Documented bibliographic addition; requires local scientific approval before use as a master formulation record.
The master formula and patient leaflet differ in quantity/units. The explicit master formula is used; this interpretation requires approval before preparation. See Notes.
Source formula
| Ingredient | Source quantity |
|---|---|
| Racemic menthol | 1 g |
| Thymol | 1 g |
| Rosemary spirit PO035 | q.s. ad 100 mL |
Quantities refer to the source batch. This website does not automatically scale formulas, assign doses or calculate BUD.
Description
Documented in sourceClear colourless liquid with a characteristic odour.
References: [1]
Use and action
Documented in sourceAEMPS describes external rubbing for symptomatic relief of muscle/joint pain and mild itching.
References: [1]
Specifications
Partial evidenceClear colourless liquid with a characteristic odour. Quantities/raw-material quality follow §3. No specific numerical finished-product assay limit is provided.
References: [1]
Light
Documented in sourceThe finished preparation is stored protected from light under the monograph.
References: [1]
Air
Partial evidenceEthanol generates vapour; limit time in open vessels. Evaporation can change composition (editorial process assessment).
References: [6]
Water and solubility
Partial evidenceEthanol is miscible with water. This does not establish that all dissolved actives remain soluble after dilution.
Racemic menthol is practically insoluble in water and very soluble in ethanol under PA021.
Humidity
Not establishedNo specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.
References: [1]
Temperature
Partial evidenceFinished-product storage: Below 25°C, tightly closed and protected from light. Processing follows the method-specific temperatures.
References: [1]
pH and related incompatibilities
Not establishedNo specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.
References: [1]
Other incompatibilities
Partial evidenceMenthol forms eutectic mixtures with camphor/thymol; incompatible with strong oxidants.
Thymol: incompatible with oxidants/alkalis; proteins reduce antiseptic action.
Ethanol is incompatible with strong oxidants.
Ingredient-specific information
Partial evidenceExact identities: Ρακεμική μενθόλη / Racemic menthol; Θυμόλη / Thymol; Οινόπνευμα δενδρολίβανου PO035 / Rosemary spirit PO035. Use pharmacopoeial raw materials of the referenced edition, with CoA verification. Do not arbitrarily change salt, hydration state or strength. Record the actual q.s. amount in the batch.
References: [1]
Compounding conditions
Documented in sourceLaboratory environment under the referenced AEMPS procedure: 25±5°C and relative humidity ≤60%, unless the specific formulation requires otherwise. Room temperature differs from processing temperature.
References: [2]
Personal protective equipment
Partial evidenceClean protective clothing and head covering under AEMPS PN/L/PG/002/00. Use suitable gloves where contact is possible and respiratory/eye protection where powder handling requires it. Exact glove material, ventilation and respiratory protection must follow the SDS and local exposure assessment.
Menthol: eye protection and prevention of contact/dust inhalation.
Risks and precautions
Partial evidencePossible irritant/allergic dermatitis and inhalation irritation. Ingestion can cause severe toxicity. The vehicle has a high alcohol content.
Ethanol: flammable vapour; control ignition sources and provide suitable ventilation. Final classification depends on concentration/mixture.
BUD rationale
Partial evidenceThe specific monograph states 3 months under its specified conditions. This is a source period, not independently verified stability of the local batch. Match composition, preservative, container and storage, check applicable requirements and obtain responsible approval. The actual date remains blank.
References: [1]
Bases and dependencies
Documented in sourceCGR-ES-076 — Αλκοολικό διάλυμα αιθέριου ελαίου δενδρολίβανου 5% / Rosemary essential oil alcoholic solution 5% v/v
Referenced bases are included in the package; also check their dependencies.
Equipment
Editorial checklistBalance with suitable resolution, mortar/spatula, suitable mixing vessels and final container. Add volumetric equipment for mL, a controlled water bath where melting is specified and a suitable filter where required. Analytical equipment follows the QC methods.
References: [2]
Preparation procedure
Documented in source1. Prepare and check rosemary spirit 5% PO035.
2. Dissolve menthol and thymol in part of the vehicle.
3. Filter and make up to 100 mL with the same vehicle under PN/L/FF/007/00.
Observations
Partial evidenceThe master formula is 100 mL. The leaflet heading “100 g” conflicts with its own ad 100 mL and is not used to change the formula basis.
References: [1]
Packaging
Documented in sourceAmber glass bottle.
References: [1]
Labelling
editorial_specimenMenthol 1% and thymol 1% rubefacient in rosemary spirit
Quantity: _____ · Batch: _____ · Prepared: _____ · Use by: _____
External use only. Storage: Below 25°C, tightly closed and protected from light.
Patient/directions or laboratory use: _____ · Pharmacy/telephone: _____
Flammable. Keep away from flames. Do not swallow.
Specimen for pharmacist adaptation; not a final approved label.
Quality control
Partial evidenceUnder AEMPS: organoleptic properties and final mass and/or volume. For batches: colour RFE 2.2.2, clarity/opalescence RFE 2.2.1, relative density RFE 2.2.5, pH under PN/L/CP/001/00 and microbiological testing under RFE 5.1.4. This formula provides no numerical pH/density limits or specific active assay.
Storage
Documented in sourceBelow 25°C, tightly closed and protected from light.
References: [1]
Dispensing and directions
Documented in sourceDO NOT SWALLOW. EXTERNAL USE ONLY. The source gives 2–3 applications/day with gentle rubbing. Do not use under age 2, on open wounds or mucosa, or near the nose. Pregnancy/breastfeeding require medical assessment.
References: [1]
Sources and traceability
- FN/2003/PO/026 SOLUCIÓN RUBEFACIENTE
FN/2003/PO/026 · Master formula §§3–4; packaging/storage §5; description §6; period §7; use/precautions §§8–12 and patient leaflet · A1 official formulary
Review date reported in supplied metadata: 2026-09-10
- PN/L/FF/007/00 ELABORACIÓN DE SOLUCIONES
PN/L/FF/007/00 · §4.3 environment; §4.4 method; §4.6 controls · A2 official technical guidance
Review date reported in supplied metadata: 2026-09-10
- PN/L/PG/002/00 INDUMENTARIA
PN/L/PG/002/00 · Clothing and protective equipment · A2 official technical guidance
Review date reported in supplied metadata: 2026-09-10
- FN/2003/PA/021 MENTOL RACÉMICO
FN/2003/PA/021 · Raw-material properties, handling and incompatibilities · A1 official formulary
Review date reported in supplied metadata: 2026-09-10
- FN/2003/PA/037 TIMOL
FN/2003/PA/037 · Raw-material properties, handling and incompatibilities · A1 official formulary
Review date reported in supplied metadata: 2026-09-10
- niosh_ethanol
Official agency page · Raw-material properties, handling and incompatibilities · A2 official technical guidance
Review date reported in supplied metadata: 2026-09-10
- FN/2006/PO/035 ALCOHOL DE ROMERO AL 5%
FN/2006/PO/035 · PDF pp. 1–3 · A1 official formulary
Review date reported in supplied metadata: 2026-09-10
- AEMPS — Aviso legal
Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence
Review date reported in supplied metadata: 2026-09-10
- BOE — Real Decreto 1495/2011, artículos 7–10 y anexo
Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence
Review date reported in supplied metadata: 2026-09-10
Provenance and reuse
Source: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Formulario Nacional. Original Greek/English rendering and restructuring: Greek Formulary Sikalias, Stasinos Chr. Sikalias, compounding.gr. Reuse basis: AEMPS legal notice and RD 1495/2011, Articles 7–10/Annex. Composition and units retained; references, distinct editorial notes and blank batch fields added. AEMPS endorsement is not implied. Edition code appears in the reference; NIPO 134-20-002-3 / 090-22-245-5. The PDFs do not state an exact internal revision date. Access checked 10 September 2026. CDC/NIOSH sources are freely available from CDC; brief technical paraphrases imply no CDC endorsement.
SHA-256 of the supplied PDF: 534e59fe77d815f71c9126c137d436d298f86acb0707e5deb24bd981605639d6